About Mohammad Muhsin Chisti
10+ Years of Experience
Pleural and Lung Cancer
Excellence in Research
In addition to his role at Beaumont, Chisti is the medical director of research at Karmanos Cancer Institute, focusing on novel, targeted therapies that are providing new hope for once-incurable diseases.
“My mission is to provide evidence-based, compassionate care to achieve the best possible outcome, with an emphasis on quality of life,” Chisti said. “I look forward to caring for patients and their families.”
Treating Multiple Cancers
Chisti sees patients with lung cancer, pleural mesothelioma, breast cancer, prostate cancer, multiple myeloma and lymphoma.
As an assistant professor of oncology at Karmanos, he also has affiliations with St. Joseph Mercy Oakland and McLaren Oakland hospitals.
Chisti speaks multiple languages, including Urdu, Kashmiri and Hindi.
He was one of 10 doctors from the staff at Karmanos Cancer Institute who were named to Hour Detroit Magazine’s Top Doctor List 2017.
Chisti is a member of the American Society of Hematology, the American Society of Clinical Oncology and the American College of Physicians.
Breaking New Ground with Immunotherapy
Chisti has co-authored numerous studies involving targeted immunotherapy. One of those in 2018 included combined B-cell and T-cell disorders that lead to debilitating conditions.
In 2019, he co-authored another study in BMJ, formerly British Medical Journal, that illustrated the therapeutic efficacy of the cancer drug lenalidomide in patients with chromosomal disorders.
“Things have changed tremendously [in cancer treatment],” he said. “It’s amazing how much things have changed. We have genetically engineered cells today that are very focused, very targeted that can bind to cancer cells and kill them.”
Before joining Beaumont in 2010, Chisti finished residencies in Internal Medicine at Roswell Park Cancer Institute, the University of Buffalo and State University of New York. He first came to Beaumont as a fellow.
He earned his degree from Government Medical College Srinagar in India. He served as a junior resident at nearby Modern Hospital and then at Sheri-Kashmir Institute of Medical Science.
Disclaimer: Dr. Mohammad Muhsin Chisti has no professional affiliation with Asbestos.com.
5 Cited Article Sources
The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.
Sanders, D. et.al. (2019, April 20). MDS with 5q deletion and rare cKIT positive mastocytosis: a diagnostic and therapeutic challenge.
Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/31005862
Medscape. (2018, December 16). Combined B-Cell and T-Cell Disorders.
Retrieved from: https://emedicine.medscape.com/article/210249-overview
Karmanos Cancer Institute. (2017, October 4). News – Karmanos physicians named Hour Detroit’s 2017 Top Doctors.
Retrieved from: https://www.karmanos.org/News/KarmanosphysiciansnamedHourDetroits2017TopDoctors?showBack=true&PageIndex=1
Beaumont. (n.d.). About Mohammad Muhsin Chisti.
Retrieved from: https://doctors.beaumont.org/provider/Mohammad+Muhsin+Chisti/226836#provider-details-experience
- Mohammad Muhsin Chisti. (n.d.). About Dr. Chisti. Retrieved from: http://www.mohammadmuhsinchistimd.com/
How did this article help you?
What about this article isn’t helpful for you?
Did this article help you?
Share this article
Last Modified July 11, 2019